A two part, randomized, placebo controlled study to evaluate the pharmacokinetics and cardiovascular pharmacodynamics of AEB071 in combination with ritonavir in healthy volunteers.
Phase of Trial: Phase II
Latest Information Update: 13 Apr 2015
At a glance
- Drugs Sotrastaurin (Primary) ; Ritonavir
- Indications Liver transplant rejection; Psoriasis; Renal transplant rejection
- Focus Pharmacokinetics
- Sponsors Novartis
- 11 Apr 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
- 26 Aug 2011 New trial record